🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

7,888 results for “1” Clear

  1. AMOXICILINA NORMON 1000 mg Comprimidos EFG

    The George Institute

    Infective endocarditis

    approved small molecule active

    1 trial

  2. AMOXICILLIN

    Pari Pharma GmbH

    Adults diagnosed with lower limbs erysipelas

    approved small molecule active

    1 trial

  3. AMOXICILLIN AND BETA-LACTAMASE INHIBITOR , CEFEPIME , CEFOTAXIME, SPIRAMYCIN , PIPERACILLIN AND BETA-LACTAMASE INHIBITOR

    Pari Pharma GmbH

    EA-COPD (with mechanical ventilation, invasive or non-invasive, or high-flow nasal oxygen therapy).

    approved small molecule active

    1 trial

  4. AMPICILLIN , AMOXICILLIN AND BETA-LACTAMASE INHIBITOR , OFLOXACIN , MOXIFLOXACIN , AZITHROMYCIN , LEVOFLOXACIN , AMOXICILLIN , PRISTINAMYCIN , ERYTHROMYCIN , CIPROFLOXACIN , CLARITHROMYCIN

    Pari Pharma GmbH

    Community acquired pneumonia (CAP)

    approved small molecule active

    1 trial

  5. AO-128

    Takeda

    Impaired Glucose Tolerance (IGT)

    approved small molecule completed

    1 trial

  6. ARALAST Alpha1-Proteinase Inhibitor

    Takeda

    Alpha1-antitrypsin Deficiency

    approved small molecule terminated

    1 trial

  7. ASS-ratiopharm® 100 mg TAH Tabletten, Xarelto 15 mg film-coated tablets

    The George Institute

    Risk of stroke by Atrial Fibrillation

    approved small molecule active

    1 trial

  8. ATORVASTATIN, PLACEBO

    Disc Medicine

    Atherosclerosis

    approved small molecule active

    1 trial

  9. AZD1222

    AstraZeneca

    COVID-19, SARS-CoV-2

    approved mab terminated

    1 trial

  10. Acarbose 100 MG

    RenJi Hospital

    PCOS

    approved small molecule active

    1 trial

  11. Acetylsalicylzuur Aurobindo cardio 80 mg, tabletten.

    Disc Medicine

    ST elevation myocardial infarction (STEMI)

    approved small molecule active

    1 trial

  12. Adrenalina B. Braun 1 mg/ml Solución Inyectable, Ropivacaína B. Braun 2 mg/ml solución inyectable y para perfusión EFG

    The George Institute

    Knee Osteoarthritis

    approved small molecule active

    1 trial

  13. Adult group in immunogenicity and safety study of combined immunization

    Sinovac Research and Development Co.,

    COVID-19

    approved mab completed

    1 trial

  14. Advair Diskus100/50 µg

    Teva Pharma GmbH

    Asthma

    approved small molecule completed

    1 trial

  15. Advair HFA 230mcg/21mcg, Dupixent 300 mg solution for injection in pre-filled syringe, Placebo matching to dupilumab, Advair HFA 115 mcg/21 mcg

    Lacuna Pharma Pty Ltd

    Asthma

    approved small molecule active

    1 trial

  16. Aerosolized 13 cis retinoic acid plus Vitamin D

    The First People's Hospital of Lianyungang

    Post COVID-19 Anosmia (Loss of Smell)

    approved small molecule active

    1 trial

  17. Aflibercept (BAY86-5321, Eylea)

    Regeneron UK Limited

    Diabetic Macular Edema

    approved small molecule completed

    1 trial

  18. Aflibercept (Eylea, VEGF Trap-Eye, BAY86-5321)

    Regeneron UK Limited

    Wet Macular Degeneration

    approved small molecule completed

    1 trial

  19. Aflibercept (Eylea, VEGF Trap-Eye, BAY86-5321)

    Regeneron UK Limited

    Neovascular Macular Degeneration

    approved small molecule completed

    1 trial

  20. Aflibercept 8 mg (VEGF Trap-Eye, BAY86-5321)

    Regeneron UK Limited

    Diabetic Macular Edema (DME)

    approved small molecule active

    1 trial

  21. Alecensa 150 mg hard capsules

    Disc Medicine

    ALK positive non-small cell lung cancer

    approved small molecule active

    1 trial

  22. Alirocumab 150 MG/ML subcutaneous injection

    Regeneron UK Limited

    Saphenous Vein Graft Atherosclerosis

    approved small molecule terminated

    1 trial

  23. Alirocumab, Placebo product for REGN727

    The George Institute

    Cardiac allograft vaculopathy in recent heart transplant recipients

    approved small molecule active

    1 trial

  24. Almax Forte 1,5 g suspensión oral

    Almirall, S.A.

    heartburn and or reflux

    approved small molecule active

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources